PER
Click for more information
5.00% 8.4¢ percheron therapeutics limited

Ann: MHRA approval for ATL1102 Phase IIb DMD clinical trial in UK, page-8

  1. arjay
    3,543 Posts.
    lightbulb Created with Sketch. 771
    clock Created with Sketch.
    27/06/23
    15:59
    Post #: 68494888
    Very happy...absolutely fantastic...well done CG and all holders....patience will be rewarded....

    EU is a huge market...and we all know Sarepta is not allowed to sell in EU...

    If they are interested ....yes with a few hundred million we may think about a deal if CG is in a good mood...lol

    Go ANP....
    ANP Price at posting: 6.4¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 21  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
NEWS Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom
right-arrow Created with Sketch.
EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
NEWS Has uranium run out of steam? An update on nuclear markets & developments ahead in FY25
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.4¢ 		Change
0.004(5.00%) 		Mkt cap ! $75.72M
Open High Low Value Volume
8.0¢ 8.4¢ 8.0¢ $26.89K 328.0K

Buyers (Bids)

No. Vol. Price($)
1 9602 8.3¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 58051 1
View Market Depth
Last trade - 16.10pm 03/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.